Lista de obras - Paolo A Muraro - Dominio Público Uruguay

2',3'-cyclic nucleotide 3'-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases

artículo científico publicado en 1997

A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.

artículo científico publicado en 2012

Age and disability accumulation in multiple sclerosis

artículo científico publicado en 2011

Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis

artículo científico publicado en 2014

Author Correction: Immune reconstitution therapies: concepts for durable remission in multiple sclerosis

artículo científico publicado en 2020

Autologous HSCT for advanced MS: Is the glass half-empty or really half-full?

artículo científico publicado en 2008

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joi

scientific article published on 26 September 2019

Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis

artículo científico publicado en 2009

Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?

artículo científico publicado en 2012

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

artículo científico publicado en 2009

Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis

artículo científico publicado en 2006

Comprehensive Analysis of TCR-β Repertoire in Patients with Neurological Immune-mediated Disorders

artículo científico publicado en 2019

Decreased integrin gene expression in patients with MS responding to interferon-beta treatment

artículo científico publicado en 2004

Development of oral immunomodulatory agents in the management of multiple sclerosis

artículo científico publicado en 2011

Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones

artículo científico publicado en 1999

Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response

artículo científico publicado en 2007

Drugs in development for relapsing multiple sclerosis

artículo científico publicado en 2013

Early Relapses, Onset of Progression, and Late Outcome in Multiple Sclerosis

artículo científico publicado en 2013

Emerging therapies for multiple sclerosis

artículo científico publicado en 2007

Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, M

artículo científico publicado en 2005

Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status

artículo científico publicado en 2020

Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms

artículo científico publicado en 2018

Hematopoietic stem cell transplantation for multiple sclerosis

artículo científico publicado en 2005

Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies

artículo científico publicado en 2010

Immune re-education following autologous hematopoietic stem cell transplantation

artículo científico publicado en 2008

Immune reconstitution therapies: concepts for durable remission in multiple sclerosis

scientific article published on 24 October 2019

Immuno-therapeutic potential of haematopoietic and mesenchymal stem cell transplantation in MS.

artículo científico publicado en 2010

Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire

artículo científico publicado en 1997

Immunological questions on hematopoietic stem cell transplantation for multiple sclerosis.

artículo científico publicado en 2003

In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.

artículo científico publicado en 2014

In vitro modulation of human, autoreactive MBP-specific CD4+ T-cell clones by cyclosporin A

artículo científico publicado en 1997

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

artículo científico publicado en 2006

Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis

artículo científico publicado en 2005

Is there a place for 'immuno' in the immunotherapy of multiple sclerosis?

artículo científico publicado en 2009

Lack of over-expression of T cell receptor Vbeta5.2 in myelin basic protein-specific T cell lines derived from HLA-DR2 positive multiple sclerosis patients and controls.

artículo científico publicado en 1998

Limited repertoire of HLA-DRB10401-restricted MBP111-129-specific T cells in HLA-DRB10401 Tg mice and their pathogenic potential

artículo científico publicado en 2004

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

artículo científico publicado en 2017

Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis

artículo científico publicado en 2012

Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005).

artículo científico publicado en 2006

Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis

artículo científico publicado en 2013

Onset of secondary progressive phase and long-term evolution of multiple sclerosis

artículo científico publicado en 2013

Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution

artículo científico publicado en 2007

Plaques, T cells and beyond: report on an international meeting on the immunological basis of multiple sclerosis held at the University of Chieti, Italy

artículo científico publicado en 1999

Positron emission tomography imaging in multiple sclerosis-current status and future applications

artículo científico publicado en 2011

Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7

artículo científico publicado en 1999

Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease

artículo científico publicado en 2012

Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vβ analysis

article

Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity

artículo científico publicado en 2005

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

artículo científico publicado en 2014

Renewing the T cell repertoire to arrest autoimmune aggression

artículo científico publicado en 2006

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

artículo científico publicado en 2015

Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing–remitting MS

artículo científico publicado en 2002

T cell repertoire following autologous stem cell transplantation for multiple sclerosis

scientific article published on 17 February 2014

T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients

artículo científico publicado en 2002

T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft

artículo científico publicado en 2009

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

artículo científico publicado en 2010

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

artículo científico publicado en 2005

Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research

artículo científico publicado en 2012

Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice

artículo científico publicado en 2004

Using stem cells in multiple sclerosis therapies

artículo científico publicado en 2004

VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis

artículo científico publicado en 2000

Lista de obras de Paolo A Muraro

2',3'-cyclic nucleotide 3'-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases

A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.

Age and disability accumulation in multiple sclerosis

Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis

Author Correction: Immune reconstitution therapies: concepts for durable remission in multiple sclerosis

Autologous HSCT for advanced MS: Is the glass half-empty or really half-full?

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joi

Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis

Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis

Comprehensive Analysis of TCR-β Repertoire in Patients with Neurological Immune-mediated Disorders

Decreased integrin gene expression in patients with MS responding to interferon-beta treatment

Development of oral immunomodulatory agents in the management of multiple sclerosis

Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones

Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response

Drugs in development for relapsing multiple sclerosis

Early Relapses, Onset of Progression, and Late Outcome in Multiple Sclerosis

Emerging therapies for multiple sclerosis

Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, M

Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status

Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms

Hematopoietic stem cell transplantation for multiple sclerosis

Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies

Immune re-education following autologous hematopoietic stem cell transplantation

Immune reconstitution therapies: concepts for durable remission in multiple sclerosis

Immuno-therapeutic potential of haematopoietic and mesenchymal stem cell transplantation in MS.

Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire

Immunological questions on hematopoietic stem cell transplantation for multiple sclerosis.

In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.

In vitro modulation of human, autoreactive MBP-specific CD4+ T-cell clones by cyclosporin A

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis

Is there a place for 'immuno' in the immunotherapy of multiple sclerosis?

Lack of over-expression of T cell receptor Vbeta5.2 in myelin basic protein-specific T cell lines derived from HLA-DR2 positive multiple sclerosis patients and controls.

Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis

Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005).

Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis

Onset of secondary progressive phase and long-term evolution of multiple sclerosis

Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution

Plaques, T cells and beyond: report on an international meeting on the immunological basis of multiple sclerosis held at the University of Chieti, Italy

Positron emission tomography imaging in multiple sclerosis-current status and future applications

Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7

Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease

Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vβ analysis

Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

Renewing the T cell repertoire to arrest autoimmune aggression

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing–remitting MS

T cell repertoire following autologous stem cell transplantation for multiple sclerosis

T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients

T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research

Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice

Using stem cells in multiple sclerosis therapies

VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis

Limited repertoire of HLA-DRB10401-restricted MBP111-129-specific T cells in HLA-DRB10401 Tg mice and their pathogenic potential